Neuroendocrine tumor treatment
DC CAFC
First Claim
Patent Images
1. A method for treating pancreatic neuroendocrine tumors, comprising administering to a human subject in need thereof a therapeutically effective amount of 40-O-(2-hydroxyethyl)-rapamycin as a monotherapy and wherein the tumors are advanced tumors after failure of cytotoxic chemotherapy.
1 Assignment
Litigations
4 Petitions
Accused Products
Abstract
A method for treating endocrine tumors by administration of an mTOR inhibitor, optionally in combination with another drug.
-
Citations
3 Claims
- 1. A method for treating pancreatic neuroendocrine tumors, comprising administering to a human subject in need thereof a therapeutically effective amount of 40-O-(2-hydroxyethyl)-rapamycin as a monotherapy and wherein the tumors are advanced tumors after failure of cytotoxic chemotherapy.
Specification
-
- Resources
Litigation Campaign Assessment
Thank you for your request. You will receive a custom alert email when the Litigation Campaign Assessment is available.
×
Litigation Data
-
Current AssigneeNovartis Ag
-
Original AssigneeNovartis Ag
-
InventorsMarks, Peter Wayne, Lebwohl, David
-
Primary Examiner(s)JEAN-LOUIS, SAMIRA JM
-
Application NumberUS12/094,173Publication NumberTime in Patent Office3,067 DaysField of SearchUS Class Current514/183CPC Class CodesA61K 31/436 the heterocyclic ring syste...A61K 38/31 SomatostatinsA61K 45/06 Mixtures of active ingredie...A61P 25/00 Drugs for disorders of the ...A61P 35/00 Antineoplastic agentsA61P 35/04 specific for metastasisA61P 43/00 Drugs for specific purposes...
